Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
2,860
-3,993
-58% -$1.37M 0.22% 106
2026
Q1
$2.41M Sell
6,853
-24
-0.3% -$8.56K 0.57% 39
2025
Q4
$2.25M Sell
6,877
-79
-1% -$25.1K 0.54% 44
2025
Q3
$1.96M Sell
6,956
-74
-1% -$21.5K 0.48% 51
2025
Q2
$1.96M Buy
+7,030
New +$1.99M 0.51% 50
2024
Q4
$1.79M Buy
6,875
+758
+12% +$225K 0.54% 48
2024
Q3
$1.97M Buy
6,117
+118
+2% +$38.6K 0.6% 44
2024
Q2
$1.87M Buy
5,999
+209
+4% +$61.4K 0.6% 39
2024
Q1
$1.65M Buy
+5,790
New +$1.69M 0.56% 43

Other funds holding AMGN

Hilltop National Bank's AMGN Position: Q2 2026 in Review

Hilltop National Bank reduced its Amgen (AMGN) stake by 58% in Q2 2026, selling an estimated $1.37M and leaving 2,860 shares worth $1.04M. The position accounts for 0.22% of the portfolio, ranked #106.

Hilltop National Bank first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.41M in Q1 2026. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hilltop National Bank held 2,860 shares of Amgen worth $1.04M as of Q2 2026.
  • Hilltop National Bank sold 3,993 Amgen shares in Q2 2026, an estimated $1.37M.
  • Amgen made up 0.22% of Hilltop National Bank's portfolio in Q2 2026, its #106 holding.
  • Hilltop National Bank first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • Hilltop National Bank's Amgen position peaked at $2.41M in Q1 2026.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.